Molecular Mechanism of Treating Different Diseases with Same Treatment of Gypenoside L Affecting Oxidative Damage HUVEC and OVCAR-3 Through EGFR/STAT3/Glycolytic Pathway
|更新时间:2025-04-30
|
Molecular Mechanism of Treating Different Diseases with Same Treatment of Gypenoside L Affecting Oxidative Damage HUVEC and OVCAR-3 Through EGFR/STAT3/Glycolytic Pathway
“The latest research found that gypenoside L can reduce the occurrence and development of atherosclerosis and ovarian cancer by inhibiting EGFR/STAT3/HK2 pathway.”
Chinese Journal of Experimental Traditional Medical FormulaeVol. 31, Issue 11, Pages: 125-134(2025)
YANG Ying,ZHAO Jiao,SUN Xiaofei,et al.Molecular Mechanism of Treating Different Diseases with Same Treatment of Gypenoside L Affecting Oxidative Damage HUVEC and OVCAR-3 Through EGFR/STAT3/Glycolytic Pathway[J].Chinese Journal of Experimental Traditional Medical Formulae,2025,31(11):125-134.
YANG Ying,ZHAO Jiao,SUN Xiaofei,et al.Molecular Mechanism of Treating Different Diseases with Same Treatment of Gypenoside L Affecting Oxidative Damage HUVEC and OVCAR-3 Through EGFR/STAT3/Glycolytic Pathway[J].Chinese Journal of Experimental Traditional Medical Formulae,2025,31(11):125-134. DOI: 10.13422/j.cnki.syfjx.20250214.
Molecular Mechanism of Treating Different Diseases with Same Treatment of Gypenoside L Affecting Oxidative Damage HUVEC and OVCAR-3 Through EGFR/STAT3/Glycolytic Pathway